Sponsor intelligence · OTHER
Clinical trials sponsored by
Institute Of Hematology & Blood Diseases Hospital, China.
Real, source-linked trial activity for Institute Of Hematology & Blood Diseases Hospital, China: 8 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Nov 3, 2026. Source-linked, daily-refreshed.
NA 4PHASE1 2PHASE2 1PHASE3 1
Newest Institute Of Hematology & Blood Diseases Hospital, China trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 6d ago | A Randomized, Controlled Clinical Study on the Efficacy and Safety of | Ph 2 | COMPLETED | ↗ |
| 6d ago | Impact of Closed PBSC Collection With Reduced Gas-Phase Oxygen Exposur | NA | NOT_YET_RECRUITING | ↗ |
| 9d ago | Efficacy and Safety of Maximum Labeled Dose Luspatercept in Lower-Risk | Ph 3 | NOT_YET_RECRUITING | ↗ |
| 35d ago | Nutritional Intervention for Patients Undergoing Allogeneic Hematopoie | NA | NOT_YET_RECRUITING | ↗ |
| 35d ago | Clinical Study of UC-MSC Combined With Immunosuppressive Agents in the | NA | COMPLETED | ↗ |
| 42d ago | Human Albumin Combined With Plasma Exchange for Frailty Intervention | NA | NOT_YET_RECRUITING | ↗ |
| 47d ago | Liposomal Mitoxantrone Plus Azacitidine and Venetoclax in Newly Diagno | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 54d ago | Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic A | Ph 1 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Institute Of Hematology & Blood Diseases Hospital, China (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.